B7-H3 in Cancer Immunotherapy—Prospects and Challenges: A Review of the Literature
In today’s oncology, immunotherapy arises as a potent complement for conventional cancer treatment, allowing for obtaining better patient outcomes. B7-H3 (CD276) is a member of the B7 protein family, which emerged as an attractive target for the treatment of various tumors. The molecule modulates an...
Shranjeno v:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-08-01
|
| Serija: | Cells |
| Teme: | |
| Online dostop: | https://www.mdpi.com/2073-4409/14/15/1209 |
| Oznake: |
Brez oznak, prvi označite!
|